
SS-31 (Elamipretide) is a synthetic mitochondria-targeted tetrapeptide that stabilizes cardiolipin in the inner mitochondrial membrane, restoring electron transport chain efficiency and ATP production. It's one of the few mitochondrial peptides with human clinical trial data.
Research-context information only. SS-31 is a research peptide. Protocols, doses, and reactions reported below come from published research and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
SS-31 (elamipretide) is FDA-approved only for Barth syndrome, under a September 2025 accelerated approval to improve muscle strength in patients weighing at least 30 kg (Shirley, 2026). Research-grade SS-31 sold by peptide vendors is not an approved product, and the community doses below are not part of that approval. Everything below reflects published clinical trial and community protocols. This is not medical advice.
SS-31 (Elamipretide) Dosing Table
Match your vial size below — reconstitution and dose math update automatically.
| Dose | Syringe units | mL volume | Schedule |
|---|---|---|---|
| 500 mcg | 10 units | 0.1 mL | AM SubQ, 5-on/2-off (8 wk on / 8 wk off)Community protocol |
| 1 mg | 20 units | 0.2 mL | Daily SubQOther reported, higher |
Math assumes U-100 insulin syringes (1 mL = 100 units). Verify your syringe matches before injecting. Round half-units to the nearest visible mark.
Quick Reference: Commonly Reported Protocol
Protocol parameters documented in clinical trials and community sources:
| Parameter | Documented value |
|---|---|
| Vial | 10 mg |
| BAC Water | 2 mL |
| Concentration | 5 mg/mL |
| Dose (community) | 500 mcg (10 units, standard 5 mg/mL reconstitution) |
| Route | Subcutaneous (all community protocols) |
| Timing | Morning (most community sources) |
| Frequency | 5 days on, 2 days off (community protocol) |
| Cycle | 8 weeks on, 8 weeks off (community protocol) |
| Storage | 2–8 °C, within 28 days (community protocol) |
Cycling Details
Community protocols describe 500 mcg daily for 5 consecutive days, then 2 days off, continuing this pattern for 8 weeks, then 8 weeks off before repeating.
SS-31's rapid mitochondrial uptake (>1,000-fold concentration within minutes) means no loading phase is necessary. Community sources describe the 5on/2off pattern within the 8-week cycle as a way to limit potential desensitization, and the 8-week off period as a window to assess sustained effects; neither pattern has been tested in a trial.
Morning injection is most common in community reports. Some users report dosing 30-60 minutes pre-workout.
Routes of Administration
Subcutaneous injection is the standard community route. Protocols describe injecting into abdomen, thigh, or anywhere with SC fat. Volume is 0.1 mL with insulin syringe (29-31 gauge).
Intravenous is used only in clinical trials — provides rapid peak plasma levels but shorter tissue exposure than SC. Not practical for self-administration.

Reconstitution Quick Reference
| Vial Size | BAC Water | Concentration | 500 mcg Dose |
|---|---|---|---|
| 10 mg | 2 mL | 5 mg/mL | 10 units |
Math: 10 mg / 2 mL = 5 mg/mL = 5,000 mcg/mL. For 500 mcg: 500 / 5,000 = 0.1 mL = 10 units.
Reconstitution protocols describe swirling gently rather than shaking, with refrigerated storage at 2-8 °C for up to 28 days. For step-by-step instructions, see the full SS-31 Reconstitution Guide.
Ready to buy? Compare verified vendors on our best SS-31 sources page, or browse all coupon codes for up to 50% off. For COA verification, vial size trade-offs, and a vendor-by-vendor price breakdown, see the full SS-31 Buying Guide.





